2026 Annual Meeting | H82 - Negotiating Team Roles and Making Contributions to Industry Research (Research Hub)

Date Sunday 04/19/26

Time 02:30 PM - 03:30 PM CDT Add To Calendar

Location McCormick Place West | W193b

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Research)

Director(s) Claire Riley, MD, FAAN, Priya U. Kumthekar, MD, Neal S. Parikh, MD, James M. Stankiewicz, MD, FAAN

Topic(s) Education, Research, and Methodology

Learning Objectives So, you have an opportunity to work with industry-based research. What's next? A wide range of operational assets will be discussed. This includes a joint vision, negotiating team roles, effective execution, collaboration, recognition, and authorship.

CME Available No CME available

Program Materials Program Evaluations

Event Timeline
02:30 PM - 02:45 PM CDT	Speaker	Industry and Academics: Working Together for a Shared Vision and Joint Execution James M. Stankiewicz, MD, FAAN
02:45 PM - 03:00 PM CDT	Speaker	How Academic Researchers Can Have Productive Contributions Within an Industry Clinical Trial More Than Just Providing the Patients Neal S. Parikh, MD
03:00 PM - 03:15 PM CDT	Speaker	Recognition, Authorship, and Collaboration with Integrity with Industry Partners Priya U. Kumthekar, MD
03:15 PM - 03:30 PM CDT	Q&A	Facilitated Discussion with Speakers Claire Riley, MD, FAAN

Faculty Disclosures
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Priya U. Kumthekar, MD	Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Enclear. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orbus Therapeutics. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioclinica. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Exelixis. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Telix . Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Plus Therapeutics. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Belay Diagnostics. Dr. Kumthekar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for FYR Diagnostics. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BPGBio. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daikonos. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Servier.